SfN 2026

Society for Neuroscience Annual Meeting 2026

November 14-18, 2026 | Washington, D.C.
Booth #406

‍

28bio will be at SfN 2026 in Washington, D.C., helping teams evaluate their preclinical strategy — modeling disease biology, assessing neuroinflammatory and neurotoxicity risk, and predicting functional outcomes with nervous system organoids.

This year we'll be presenting new data on synaptic plasticity, microglial integration, and neuroinflammatory disease modeling, reflecting our continued work expanding CNS-3D organoids toward more complex, disease-relevant biology.

If you're interested in incorporating organoids into your disease modeling or safety programs, be sure to stop by our poster presentations and schedule time to meet with a 28bio team member.‍

‍

Product Theater Presentation
Nov 17, 2026 | 1PM-1:30PM | Exhibit Hall Focused Theater
‍
Functional Endpoints of Learning and Memory with CNS-3D Plasticity Organoids

Neurodegeneration drug attrition remains among the highest because candidates are selected on evidence that does not predict cognitive outcomes. CNS-3D Plasticity Organoids pair two human iPSC-derived cortical organoids on a custom electrode array, forming a connected neural network trainable via closed-loop stimulation. Paired with cognitive biomarker assays, the platform yields functional endpoints of learning and memory via synaptic plasticity and network potentiation.

‍

Scientific Presentations

Nov 14, 2026 | 1 PM - 5 PM | Presentation #: PSTR011.09

Immunocompetent human brain for modeling Alzheimer's Disease​

Nov 17, 8 AM - 12 PM | Presentation #: PSTR223.15

Integration of microglia into human brain organoids for modeling neuroinflammatory diseases​

Nov 17, 1 PM - 5 PM | Presentation #: PSTR287.12

Closed-loop stimulation reveals learning-related plasticity in paired human brain organoids